Location:  Home » Biomedical Engineering » Genetic Engineering of Mesenchymal Stem Cells    

Genetic Engineering of Mesenchymal Stem Cells

Genetic Engineering of Mesenchymal Stem CellsCreator: Jan A. Nolta
Publisher: Springer
Category: Book

List Price: $169.00
Buy New: $35.00
as of 2/7/2012 19:32 PST details
You Save: $134.00 (79%)

In Stock
Buy

New (19) Used (18) from $31.49

Seller: academiaboooks

Languages: English (Unknown), English (Original Language), English (Published)
Media: Hardcover
Edition: 1
Pages: 175
Number Of Items: 1
Shipping Weight (lbs): 0.9
Dimensions (in): 9.5 x 6.4 x 0.6

ISBN: 1402039352
EAN: 9781402039355

Availability: Usually ships in 1-2 business days

Also Available In:

  • Kindle Edition - Genetic Engineering of Mesenchymal Stem Cells
  • Digital - Genetic Engineering of Mesenchymal Stem Cells
  • Paperback - Genetic Engineering of Mesenchymal Stem Cells
  • Hardcover - Genetic Engineering of Mesenchymal Stem Cells

Similar Items:


Editorial Reviews:

Product Description
MSC (mesenchymal stem cells) have been reported to initiate revascularization after injury, to facilitate engraftment of blood-forming stem cells, and to reduce the incidence of graft-vs. host disease through their immune-suppressive qualities. Finally, bone marrow-derived MSC have been reported to home to areas of solid tumor revascularization, and thus may be used as delivery vehicles to target ablative agents into dividing tumor cells. Recently the characteristics of human MSC from adipose (fat) tissue have also been identified. The possibility of repairing tissues, speeding stem cell engraftment, and targeting solid tumors for specific killing, using MSC easily harvested from bone marrow, or better yet, from unwanted fat tissue, holds broad appeal, and is an intriguing possibility that could have dramatic effect on health care. This book has information on how to isolate, grow, and characterize MSC from marrow and fat, and gives important insight into how these cells may be used for gene delivery and cellular therapies in the future. Updates on emerging clinical trials are given.


In Stock
Buy